In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding
- PMID: 32805168
- DOI: 10.7326/ACPJ202008180-021
In cancer-associated VTE, apixaban was noninferior to dalteparin for recurrence and did not increase major bleeding
Abstract
Agnelli G, Becattini C, Meyer G, et al. Apixaban for the treatment of venous thromboembolism associated with cancer. N Engl J Med. 2020;382:1599-607. 32223112.
Comment on
-
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical